by DB Insurance | Apr 30, 2019 | Uncategorized
The U.S. Justice Department has joined a pair of whistleblower lawsuits alleging a drugmaker now owned by Mallinckrodt Plc improperly promoted an expensive multiple sclerosis treatment and paid kickbacks to doctors who prescribed the drug.
by DB Insurance | Apr 29, 2019 | Uncategorized
The number of measles cases in the United States has reached a 25-year peak, propelled by the spread of misinformation about the vaccine that can prevent the disease, federal health officials said on Monday.
by DB Insurance | Apr 28, 2019 | Uncategorized
Adults in the United States who were vaccinated against measles decades ago may need a new dose depending on when they received the shot and their exposure risk, according to public health experts battling the nation’s largest outbreak since the virus was deemed...
by DB Insurance | Apr 27, 2019 | Uncategorized
The U.S. Food and Drug Administration on Friday approved Regeneron Pharmaceuticals Inc’s cholesterol drug Praluent as a treatment to cut the risk of heart attacks, stroke and other major cardiovascular events.
by DB Insurance | Apr 26, 2019 | Uncategorized
The Kansas Supreme Court ruled on Friday that the state’s constitution protects a woman’s right to an abortion and upheld an injunction blocking a state law that would have banned a common second trimester abortion procedure.
